Get the Stockscreener App
1.65
14.95%
-0.29
After Hours:
1.77
0.12
+7.27%
Cocrystal Pharma Inc stock is traded at $1.65, with a volume of 208.93K.
It is down -14.95% in the last 24 hours and up +8.55% over the past month.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
See More
Previous Close:
$1.94
Open:
$1.85
24h Volume:
208.93K
Relative Volume:
3.30
Market Cap:
$16.79M
Revenue:
-
Net Income/Loss:
$-17.93M
P/E Ratio:
-0.9322
EPS:
-1.77
Net Cash Flow:
$-14.28M
1W Performance:
-5.13%
1M Performance:
+8.55%
6M Performance:
-13.61%
1Y Performance:
-5.44%
1-Day Range:
$1.65
$1.903
1-Week Range:
$1.5601
$2.19
52-Week Range:
$1.12
$3.26
Cocrystal Pharma Inc Stock (COCP) Company Profile
Name
Cocrystal Pharma Inc
Sector
Industry
Phone
(786) 459-1831
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.65 | 19.74M | 0 | -17.93M | -14.28M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 60.58B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 54.99B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
674.90 | 42.25B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.93B | 3.81B | -644.79M | -669.77M | -6.24 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-20 | Initiated | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Stock (COCP) Latest News
Cocrystal Pharma Reports Positive Phase 1 Study Results - TipRanks
Military Backs Cocrystal's Breakthrough Norovirus Drug: Phase 1 Shows Perfect Safety Profile - Stock Titan
Will Cocrystal Pharma Inc. bounce back from current supportFree Weekly Stock Opportunity Radar Scanner - Newser
Cocrystal Pharma Inc. stock outlook for YEARRisk Aware Trading Ideas with Alert Levels - Newser
Price momentum metrics for Cocrystal Pharma Inc. explainedFree Entry Zone Strategy for Consistent Profit - Newser
Will Cocrystal Pharma Inc. stock recover after recent dropAlpha Stock Picks with Chart Confirmation - Newser
How to track smart money flows in Cocrystal Pharma Inc.Stock Forecast Tools for Retail Traders - Newser
What indicators show strength in Cocrystal Pharma Inc.Free Market Entry and Exit Point Tips - Newser
Applying sector rotation models to Cocrystal Pharma Inc.Pattern Breakout Prediction for Short Term - Newser
Chart based analysis of Cocrystal Pharma Inc. trendsFree Pattern Alert With ROI Driven Strategy - Newser
Wyckoff Accumulation Phase Possible in Cocrystal Pharma Inc.AI Based High Gain Watchlist Scanner Shared - beatles.ru
How volatile is Cocrystal Pharma Inc. stock compared to the marketHigh-octane gains - Jammu Links News
What are the latest earnings results for Cocrystal Pharma Inc.Free Daily Trading Room Entry - Jammu Links News
How strong is Cocrystal Pharma Inc. company’s balance sheetFastest-growing stock picks - Jammu Links News
What is Cocrystal Pharma Inc. company’s growth strategyTake advantage of unprecedented market momentum - Jammu Links News
What makes Cocrystal Pharma Inc. stock price move sharplyGet real-time alerts on high-potential stocks - Jammu Links News
Has Cocrystal Pharma Inc. formed a bullish divergenceIntelligent Trade Forecast With AI Analytics - newser.com
What data driven models say about Cocrystal Pharma Inc.’s futurePrice Movement and Market Sentiment Analysis - newser.com
Does Cocrystal Pharma Inc. fit your quant trading modelBuy Strategy Tracker with Growth Indicators - Newser
Why is Cocrystal Pharma Inc. stock attracting strong analyst attentionAchieve breakthrough financial results - Jammu Links News
Is it the right time to buy Cocrystal Pharma Inc. stockFree Consultation - Jammu Links News
What institutional investors are buying Cocrystal Pharma Inc. stockInvest confidently with market-leading analysis - Jammu Links News
What are Cocrystal Pharma Inc. company’s key revenue driversAchieve breakthrough gains with expert advice - Jammu Links News
Risk adjusted return profile for Cocrystal Pharma Inc. analyzedShort Term Gain Strategy with AI Logic - Newser
Should I hold or sell Cocrystal Pharma Inc. stock in 2025High-yield portfolio picks - Jammu Links News
Is Cocrystal Pharma Inc. a growth stock or a value stockDiscover undervalued stocks ready to soar - Jammu Links News
How does Cocrystal Pharma Inc. compare to its industry peersIdentify undervalued stocks ready to soar - Jammu Links News
Exit strategy if you’re trapped in Cocrystal Pharma Inc.Smart Trend Analysis With Buy Point Cues - Newser
What MACD and RSI say about Cocrystal Pharma Inc.Low Risk Stock Selection Strategy Guide - Newser
Detecting support and resistance levels for Cocrystal Pharma Inc.Free Risk Adjusted Technical Entry Plan - Newser
Real time alert setup for Cocrystal Pharma Inc. performanceInvestment Timing Strategy with Market Filters - Newser
How does Cocrystal Pharma Inc. generate profit in a changing economyMarket Forecast Insights For 2025 - Jammu Links News
Cocrystal Pharma Inc. stock daily chart insightsFree AI Forecast for Trending Stocks - Newser
Analyzing net buyer seller activity in Cocrystal Pharma Inc.AI-Based Stock Behavior Forecast Engine - Newser
How Efficient Is Cocrystal Pharma Inc. at Controlling Operating CostsCapital Protection Strategy With Risk Analysis - Newser
Cocrystal Pharma Inc Stock (COCP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):